Skip to main content

Peer Review reports

From: mFOLFIRINOX versus mFOLFOX 6 as adjuvant treatment for high-risk stage III colon cancer - the FROST trial: study protocol for a multicenter, randomized controlled, phase II trial

Original Submission
31 Jul 2023 Submitted Original manuscript
16 Oct 2023 Reviewed Reviewer Report - Hans-Joachim Schmoll
27 Nov 2023 Reviewed Reviewer Report
5 Dec 2023 Author responded Author comments - Ji Yeon Kim
Resubmission - Version 2
5 Dec 2023 Submitted Manuscript version 2
20 Dec 2023 Reviewed Reviewer Report - Hans-Joachim Schmoll
24 Dec 2023 Reviewed Reviewer Report
3 Jan 2024 Author responded Author comments - Ji Yeon Kim
Resubmission - Version 3
3 Jan 2024 Submitted Manuscript version 3
14 Jan 2024 Reviewed Reviewer Report
29 Jan 2024 Reviewed Reviewer Report - Hans-Joachim Schmoll
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
31 Jan 2024 Editorially accepted
29 Mar 2024 Article published 10.1186/s12885-024-11939-x

You can find further information about peer review here.

Back to article page